Abstract
肺癌可分为非小细胞肺癌(non-small cell lung cancer, NSCLC)和小细胞肺癌,其发病率和死亡率均高居恶性肿瘤首位。本文主要就NSCLC术后辅助化疗的地位确立、辅助化疗的合适人群和化疗方案选择以及相关生物标志物研究进展作一综述。
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.3779/j.issn.1009-3419.2014.06.12
Copy DOIJournal: Chinese Journal of Lung Cancer | Publication Date: Jun 20, 2014 |
License type: CC BY 3.0 |
肺癌可分为非小细胞肺癌(non-small cell lung cancer, NSCLC)和小细胞肺癌,其发病率和死亡率均高居恶性肿瘤首位。本文主要就NSCLC术后辅助化疗的地位确立、辅助化疗的合适人群和化疗方案选择以及相关生物标志物研究进展作一综述。
Join us for a 30 min session where you can share your feedback and ask us any queries you have